Comparison | Number of studies | Odds ratio (95% CI) | p | Ï„ 2 | Q-statistic Pvalue | I2 (%) | H 2 |
---|---|---|---|---|---|---|---|
All studies conventional fluid strategies | 24 | 0.59 (0.39 to 0.89) | 0.013 | 0.19 | 0.21 | 20.2 | 1.25 |
GDT involved no clinically significantly greater fluid administration | 10 | 0.47 (0.29 to 0.76) | 0.0049 | 0 | 0.73 | 0 | 1.0 |
Clinically significantly more fluids administered with GDT | 14 | 0.70 (0.35 to 1.41) | 0.32 | 0.60 | 0.09 | 39.4 | 1.65 |
Clinically significantly more fluids administered with GDT excluding outlier study | 13 | 0.88 (0.49 to 1.58) | 0.68 | 0.18 | 0.44 | 16.7 | 1.19 |
All studies conventional fluid strategies, no inotropes | 11a | 0.55 (0.24 to 1.26) | 0.16 | 0.97 | 0.03 | 52.5 | 2.11 |
All studies conventional fluid strategies, no inotropes excluding outlier study | 10a | 0.75 (0.37 to 1.53) | 0.43 | 0.38 | 0.19 | 30.8 | 1.45 |
All studies conventional fluid strategies - inotropes in GDT | 14a | 0.52 (0.34 to 0.80) | 0.0030 | 0 | 0.87 | 0 | 1.0 |
No clinically significant greater fluid administration, no inotropes | 3a | 0.47 (0.13 to 1.75) | 0.25 | 0.51 | 0.23 | 37.3 | 1.59 |
No clinically significant greater fluid administration, inotropes in GDT | 8a | 0.46 (0.27 to 0.77) | 0.0036 | 0 | 0.85 | 0 | 1.0 |
Clinically significant more fluids administered with GDT, no inotropes | 8 | 0.55 (0.18 to 1.68) | 0.30 | 1.46 | 0.02 | 60.5 | 2.53 |
Clinically significant more fluids administered with GDT, no inotropes excluding outlier study | 7 | 1.0 (0.46 to 2.17) | 0.99 | 0.19 | 0.26 | 17.2 | 1.21 |
Clinically significant more fluids administered with GDT, inotropes in GDT | 6 | 0.73 (0.31 to 1.69) | 0.46 | 0.11 | 0.61 | 8.9 | 1.1 |
Creatinine-based definition of AKI excluding outlier study | 12 | 0.61 (0.36 to 1.02) | 0.06 | 0.20 | 0.23 | 26.6 | 1.36 |
Creatinine-based definition of AKI, GDT involved no clinically significantly greater fluid administration excluding outlier study | 5 | 0.41 (0.23 to 0.72) | 0.002 | 0 | 0.83 | 0 | 1.0 |
Creatinine-based definition of AKI, clinically significantly more fluids administered with GDT excluding outlier study | 7 | 0.90 (0.41 to 1.97) | 0.80 | 0.35 | 0.18 | 33.3 | 1.5 |
GDT to assist restrictive fluid strategy in treatment arm | 3 | 1.68 (0.69 to 4.12) | 0.26 | 0 | 0.29 | 0 | 1.0 |